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Availability of Modiﬁed Dialysis for Dialysis Patient After Using Contrast
Dye in Cardiac Catheterization
Kenta Murakami,1 Ryosuke Kametani,1 Akimitsu Tanaka1
1Nagoya Tokushukai General Hospital, Japan
BACKGROUND In hemodialyzed patient, we can often seethe
complication (ex. Hypotension, bad feeling) in hemodialysis (HD) af-
ter cardiac catheterization. So we made modiﬁcation for HD after the
ﬁrst time cardiac catheterization. Content of the modify HD are that
the blood osmolality was changed slowly.
METHODS The candidate was our consecutive HD patients (218 pa-
tients, 157 male, 67.1  9.8 y.o.) who performed cardiac catheteriza-
tion from February 2009 to August 2014. From February 2009 to
December 2012 we performed usual HD after cardiac catheterization
(HD group: 157 patients). From January 2013 to August 2014 we per-
formed modiﬁed HD after that (mHD group: 61 patients). Content of
modify were that we decreased dialysis ﬂow rate (300 ml/min) in
anterior half of HD; in posterior half we performed ordinary HD. The
deﬁnition of the complication are discontinuity of HD from hypo-
tension or/and bad feeling, Unattainable of defecated water and
requisition of infusion solution.
RESULTS Developed the complication of HD group was 59 patients
(37.6 %), mHD group was 7 patients (11.3 %). It was signiﬁcant dif-
ference between the groups (p¼0.00013).
CONCLUSION Our Modifying, the blood osmolality was changed
slowly, of HD after the ﬁrst time cardiac catheterization was useful for
reducing the rate complication.
HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
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Alcohol Septal Ablation in Hypertrophic Cardiomyopathy: A Prospective
Study
Praskas Chandra Mandal,1 Debabrata Bera1
1Apollo Gleneagles Hospital, India
BACKGROUND Hypertrophic cardiomyopathy (HCM) is the most
common genetic cardiovascular disease caused by multiple muta-
tions of cardiac sarcomeres. Resting and provocable left ventricular
outﬂow tract (LVOT) gradient is a strong determinant of morbidity
and mortality in patients with hypertrophic cardiomyopathy. He-
modynamic and electrical complications are more common in pa-
tients with LVOT obstruction in compared to patients of HCM
without LVOT obstruction. Relief of LVOT obstruction improves both
symptoms and long term survival. Surgical myectomy is now the
preferred method of relieving LVOT obstruction. Alcohol septal
ablation in HCM is generally reserved for sypmtomatic patients who
are not suitable candidates for surgical myectomy. In practical sce-
nario another large proportion of patients refuse for surgical mode of
therapy. We conducted a prospective study in a tertiary care hospital
in Eastern India over last 10 years including these two groups of
patients with a goal to study immediate and long term results of
alcohol septal ablation.
METHODS We enrolled 51 patients of obstructive HCM (peak LVOT
gradient 50 mm of Hg) over 5 years (Nov 2004 to Oct 2009) who
were persistently symptomatic on medical management. Ten pa-
tients were not suitable candidates for surgery. Among the rest ofthe subjects, 26 patients refused surgical treatment. We included
only the obstructive variety (HOCM) of patients who were class III to
class IV symptomatic despite optimal medical management with
beta-blocker, calcium-channel blocker and disopyramide. Patients
with isolated mid-cavity obstruction were excluded from the study.
Alcohol septal ablation was performed on 36 patients who were not
suitable candidates for surgery or not willing to undergo surgery.
The procedure could not be completed in one patient due to he-
modynamically unstable incessant ventricular tachycardia. Subse-
quently 35 patients were followed up for next 5 years both clinically
and with echocardiography.
RESULTS The mean age at intervention was 3210 years. The peak
dynamic LVOT gradient pre-operatively was 7320 mm Hg. Alcohol
septal ablation was performed successfully in all 35 patients with
immediate LVOT gradient reduction. The peak LVOT gradient post-
operatively was 137 mm of Hg. Three patients developed complete
heart block during the procedure, among which 2 patients reverted
back spontaneously to sinus rhythm within 72 hours. One patient did
not revert back and permanent pacemaker was implanted. Over next
5-8 years follow up 4 patients died (2 patients with refractory heart
failure, 2 patients with sudden cardiac death). Three patients devel-
oped atrial ﬁbrillation over follow up. Rest of the patients is doing
well symptomatically and echocardiography showed no recurrence of
signiﬁcant LVOT obstruction.
CONCLUSION HCM is a complex genetic disorder with several long
term complications especially in the obstructive variety. Though it is
said to reserve alcohol septal ablation (Class IIa) only for those who
are not suitable candidates for surgical mectomy, a large group of
symptomatic patients who refuse for surgical option can also be
treated successfully with alcohol septal ablation. The immediate and
long-term outcome is good.
INNOVATIVE DEVICES AND FUTURISTIC THERAPIES
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Development of a Fenestrated Window Shape Aortic Arch Stent Graft with
a Preloaded Catheter for Protecting Branch Arteries: An Experimental
Study in Swine
Han Cheol Lee,1 In Sub Han,1 Hye Won Lee,1 Jun-Hyok Oh,1
Kwang Soo Cha,1 Taeg Jong Hong1
1Pusan National University Hospital, Korea (Republic of)
BACKGROUND Thoracic endovascular aortic repair (TEVAR) shows
limitations in cases where the aortic pathology involves the aortic
arch and only a short proximal landing zone is thereby available for
the stent graft. In our previous study, we developed a round shape
fenestrated aortic arch stent graft (FASG) with a preloaded catheter
for protecting branch arteries. But, FASG with round shape fenes-
tration is not available in case of emergency as aortic rupture,
complicated aortic dissection because FASG with round shape
fenestration is manufactured individually. In this study, we devel-
oped a window shape FASC with a preloaded catheter for protecting
branch arteries and performed a preclinical study with this device
in swine.
METHODS The FASG is a self-expandable nitinol-PTEF stent graft
with window shape fenestration and preloading catheter that is
designed to access right carotid artery safely. We design a window
shaped fenestration and preloading catheter placed inside the stent
graft to save blood ﬂow to the carotid, left subclavian arteries. After
window shape FASG is partially deployed, 0.35 inch guidewire is
placed into the right carotid artery and then stent graft is fully
deployed. Following separate stent graft for right carotid artery is
deployed. The sizes of fenestrated window were 30mm in width,
15mm in length and 40mm in width, 15mm in length.
Six FASGs with window shaped fenestration and a side branch
stent graft were advanced through the iliac artery in 6 swines
weighing 70–80 kg. The presence of endoleaks and the patency and
deformity of the grafts were examined with digital subtraction
angiography (DSA) at 4 weeks postoperatively. A postmortem ex-
amination was performed at 8 weeks to evaluate the gross
morphology, patency, and deformity of the FASGs with window
shaped fenestration.
